✦ LIBER ✦

Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites

✍ Scribed by Paolo Angeli; Manuela Dalla Pria; Erica de Bei; Grazia Albino; Lorenza Caregaro; Carlo Merkel; Giulio Ceolotto; Angelo Gatta

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 704 KB
Volume: 19
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840190113

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of the effects of torasemide

Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: A randomized, double-blind study

✍ Giacomo Laffi; Fabio Marra; Giampiero Buzzelli; Giuseppe Azzena; Egidio Meacci; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 628 KB

Randomized comparative study of hemaccel

Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites

✍ Francesco Salerno; Salvatore Badalamenti; Elettra Lorenzano; Pamela Moser; Pierl 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 765 KB

hemaccel with that of human albumin to sustain plasma volume after large-volume paracentesis of cirrhotic patients with refractory ascites.

Humoral response to catumaxomab correlat

Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites

✍ Marion G. Ott; Frederik Marmé; Gerhard Moldenhauer; Horst Lindhofer; Michael Hen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 893 KB

The trifunctional antibody catumaxomab is a targeted immunotherapy for the intraperitoneal treatment of malignant ascites. In a Phase II/III trial in cancer patients (__n__ = 258) with malignant ascites, catumaxomab showed a clear clinical benefit __vs__. paracentesis and had an acceptable safety pr

Rofecoxib, a specific inhibitor of cyclo

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

✍ Grant W. Cannon; Jacques R. Caldwell; Peter Holt; Barry McLean; Beth Seidenberg; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 3 views

A multicenter, randomized, double-blind

A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial

✍ Daniel L. Rubin; Terry S. Desser; Richard Semelka; Jeffrey Brown; Hanh V. Nghiem 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views

Clinical and radiographic outcomes of fo

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial

✍ Y. P. M. Goekoop-Ruiterman; J. K. De Vries-Bouwstra; C. F. Allaart; D. Van Zeben 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB 👁 3 views